Letrozole Tablets USP 2.5 mg is an oral non-steroidal Aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Siddha Global is Supplier,Exporter ,Wholesaler for Letrozole Tablets USP 2.5 mg in India.
We even offer contract manufacturing services from WHO GMP approved factories.
LETROZOLE TABLETS USP 2.5 MG
- oral non-steroidal Aromatase inhibitor